Newsroom
Newsroom
Industry News
In the Future of Everything radio show, Stanford bioengineers Russ Altman and Christina Smolke discuss advances in synthetic biology and the rise of opioids made...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...
Industry News
Over the past several months, scientists from around the world have published bits and pieces of a fascinating feat: In an effort to create pain...
Blog Posts
Upstream bioprocessing – better known in biomanufacturing as fermentation – is directly followed by downstream bioprocessing (DSP). Just as fermentation is all about maximizing the...
Blog Posts
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply chain to produce...
Blog Posts
Fermentation is one of humanity’s oldest and most pivotal technological developments. Through fermentation, societies began adapting their diets nearly ten millennia ago, to include new...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank,...
Blog Posts
Synthetic biology is often touted as a software-driven and automation-empowered approach to biological research. Buzzwords like artificial intelligence and robotics are commonly used alongside the...
Blog Posts
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people experience the...
Industry News
In the Future of Everything radio show, Stanford bioengineers Russ Altman and Christina Smolke discuss advances in synthetic biology and the rise of opioids made...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...
Industry News
Over the past several months, scientists from around the world have published bits and pieces of a fascinating feat: In an effort to create pain...
